Prognostic factors for paraconduit hernia in adult patients post-esophagectomy for cancer: a systematic review

Paraconduit hiatal hernia (PCH) is a serious complication following esophagectomy with significant morbidity and mortality. We aimed to conduct a comprehensive review to describe the prognostic factors for PCH in adult patients following esophagectomy for esophageal or gastric cancer to better understand which patients at risk. A systematic search was carried out in Ovid MEDLINE, Embase and Web-of-Science, from inception to August-2024. All studies of adult patients assessing risk factors for radiologically-confirmed PCH following esophagectomy for upper gastrointestinal cancers were included. The data showed that a minimally-invasive esophagectomy was associated with a significant increase in risk of developing PCH (odds ratio [OR]: 4.29, 95% confidence interval [CI]: 1.09-16.87; P = 0.04), particularly following laparoscopic-abdominal approach (hazard ratio [HR]: 2.98, 95% CI: 1.60-5.55; P < 0.01), and a 203% increase following extensive lymphadenectomy (OR: 3.03, 95% CI: 1.14-8.05; P = 0.03). A prophylactic-cruroplasty was not found to be associated with this complication (P = 0.18). Neoadjuvant-chemotherapy and neoadjuvant-chemoradiotherapy (nCRT) were both found to be associated with an increased risk of PCH (HR: 1.56, 95% CI: 0.58-4.17, P < 0.01; HR: 4.27 95% CI: 1.70-10.76; P < 0.01). Tumors located at gastro-esophageal-junction (GOJ) were associated with the greatest risk (HR: 3.51, 95% CI: 1.91-6.45; P < 0.01). In terms of clinical risk factors, patients with body-mass index (BMI) <25 (OR: 2.00, 95% CI: 1.10-3.70; P = 0.03), a pre-operative hiatus hernia (HH) (HR: 1.72, 95% CI: 1.01-2.94; P < 0.05) and those who had previous hiatal-surgery (HR:3.68, 95% CI: 1.61-8.45; P < 0.01) were associated with increased risk of developing PCH. The current literature suggests an associative trend between patients with BMI less than 25; nCRT; laparoscopic resection; GOJ tumor location; previous HH or hiatal surgery, and developing a PCH post-operatively.

Authors

Institutions

Publication Details

Journal
Diseases of the Esophagus
Published
2026-02-11
DOI
https://doi.org/10.1093/dote/doag017
Primary Topic
Esophageal Cancer Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prognostic factors for paraconduit hernia in adult patients post-esophagectomy for cancer: a systematic review

Amir Abdelhamid, Kareem Mahdy, George Ramsay, Shayanathan Nanthakumaran et al.
Diseases of the Esophagus
Esophageal Cancer Research and Treatment
article

Prognostic factors for paraconduit hernia in adult patients post-esophagectomy for cancer: a systematic review

Amir Abdelhamid, Kareem Mahdy, George Ramsay, Shayanathan Nanthakumaran, Abdel-Rahman Abdel Fattah
article en

Abstract

Paraconduit hiatal hernia (PCH) is a serious complication following esophagectomy with significant morbidity and mortality. We aimed to conduct a comprehensive review to describe the prognostic factors for PCH in adult patients following esophagectomy for esophageal or gastric cancer to better understand which patients at risk. A systematic search was carried out in Ovid MEDLINE, Embase and Web-of-Science, from inception to August-2024. All studies of adult patients assessing risk factors for radiologically-confirmed PCH following esophagectomy for upper gastrointestinal cancers were included. The data showed that a minimally-invasive esophagectomy was associated with a significant increase in risk of developing PCH (odds ratio [OR]: 4.29, 95% confidence interval [CI]: 1.09-16.87; P = 0.04), particularly following laparoscopic-abdominal approach (hazard ratio [HR]: 2.98, 95% CI: 1.60-5.55; P < 0.01), and a 203% increase following extensive lymphadenectomy (OR: 3.03, 95% CI: 1.14-8.05; P = 0.03). A prophylactic-cruroplasty was not found to be associated with this complication (P = 0.18). Neoadjuvant-chemotherapy and neoadjuvant-chemoradiotherapy (nCRT) were both found to be associated with an increased risk of PCH (HR: 1.56, 95% CI: 0.58-4.17, P < 0.01; HR: 4.27 95% CI: 1.70-10.76; P < 0.01). Tumors located at gastro-esophageal-junction (GOJ) were associated with the greatest risk (HR: 3.51, 95% CI: 1.91-6.45; P < 0.01). In terms of clinical risk factors, patients with body-mass index (BMI) <25 (OR: 2.00, 95% CI: 1.10-3.70; P = 0.03), a pre-operative hiatus hernia (HH) (HR: 1.72, 95% CI: 1.01-2.94; P < 0.05) and those who had previous hiatal-surgery (HR:3.68, 95% CI: 1.61-8.45; P < 0.01) were associated with increased risk of developing PCH. The current literature suggests an associative trend between patients with BMI less than 25; nCRT; laparoscopic resection; GOJ tumor location; previous HH or hiatal surgery, and developing a PCH post-operatively.

Diseases of the EsophagusVol. 39(2)
University of Aberdeen (GB), Aberdeen Royal Infirmary (GB)
Good health and well-being
Openalex Percentile: Top 37%
Esophageal Cancer Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.